-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Cyclo Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Cyclo Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$5.64M, a 21.6% decline year-over-year.
- Cyclo Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$21.2M, a 12.2% decline year-over-year.
- Cyclo Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$20.1M, a 28.3% decline from 2022.
- Cyclo Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$15.6M, a 9.32% decline from 2021.
- Cyclo Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$14.3M, a 59.5% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)